Kisan Proteins Profile
Key Indicators
- Authorised Capital ₹ 2.80 Cr
as on 16-07-2024
- Paid Up Capital ₹ 2.80 Cr
as on 16-07-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.60 Cr
as on 16-07-2024
- Satisfied Charges ₹ 9.84 Cr
as on 16-07-2024
- Revenue 109.60%
(FY 2023)
- Profit 40.23%
(FY 2023)
- Ebitda 17.76%
(FY 2023)
- Net Worth 19.68%
(FY 2023)
- Total Assets -7.55%
(FY 2023)
About Kisan Proteins
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.80 Cr and a paid-up capital of Rs 2.80 Cr.
The company currently has active open charges totaling ₹26.60 Cr. The company has closed loans amounting to ₹9.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ranchhodbhai Patel and Manubhai Patel serve as directors at the Company.
- CIN/LLPIN
U15140GJ2005PTC045282
- Company No.
045282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Palanpur, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kisan Proteins?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranchhodbhai Patel  | Director | 11-Jan-2005 | Current |
| Manubhai Patel | Director | 11-Jan-2005 | Current |
Financial Performance of Kisan Proteins.
Kisan Proteins Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 109.6% increase. The company also saw a substantial improvement in profitability, with a 40.23% increase in profit. The company's net worth Soared by an impressive increase of 19.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kisan Proteins?
In 2023, Kisan Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Jul 2023 | ₹10.00 Cr | Open |
Others Creation Date: 28 May 2021 | ₹16.60 Cr | Open |
Dena Bank Creation Date: 25 Aug 2005 | ₹9.84 Cr | Satisfied |
How Many Employees Work at Kisan Proteins?
Kisan Proteins has a workforce of 6 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kisan Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kisan Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
